Medical Weight Loss Treatment for Washington, D.C. Residents
Medically Supervised Weight Loss, Delivered Online
OmniRx Health providers are licensed by the DC Board of Medicine to deliver telehealth services throughout the District.
Whether you're in Washington, Washington, or anywhere across Washington, D.C. — our board-certified providers are ready to see you.
Medical Weight Loss Treatment in Washington, D.C.
Our board-certified providers prescribe FDA-approved and physician-developed weight loss medications including GLP-1 agonists, customized to your health profile and goals.
No office visits required — 100% online consultations
FDA-approved and physician-developed medications
Personalized dosing protocols adjusted to your response
Ongoing provider support and check-ins throughout treatment
Medications shipped directly to your door from licensed pharmacies
The nation's capital runs on ambition and tight schedules. OmniRx Health serves DC residents across all eight wards—federal workers on Capitol Hill, policy professionals in Dupont Circle, families in Northeast, and students at Georgetown and Howard. Our telehealth platform is designed for busy Washingtonians who need flexible healthcare that doesn't require taking half a day off to sit in a waiting room. Get expert care during your lunch break or after the Metro stops running.
Available Treatments in Washington, D.C.
Our board-certified providers in Washington, D.C. can prescribe and manage the following treatment options
Semaglutide
Semaglutide is a GLP-1 receptor agonist that reduces appetite and slows gastric emptying, helping patients achieve significant, sustained weight loss. Originally developed for type 2 diabetes management, semaglutide has become one of the most clinically effective weight loss medications available.
Tirzepatide
Tirzepatide is a dual GLP-1 and GIP receptor agonist that produces even greater weight loss than semaglutide alone. It addresses appetite, blood sugar regulation, and metabolic rate through two complementary hormonal pathways for superior outcomes.
Tesofensine
Tesofensine is a triple monoamine reuptake inhibitor that suppresses appetite and boosts metabolism through dopamine, norepinephrine, and serotonin pathways. Originally developed as an anti-Parkinson's agent, it showed exceptional weight loss properties in clinical trials.
Retatrutide
Retatrutide (LY3437943) is a 39-amino acid synthetic peptide and triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Currently in Phase 3 clinical trials (TRIUMPH program), it produced 24.2% average weight loss at 48 weeks in Phase 2 data — the highest weight reduction observed in any peptide trial to date. Listed by OmniRx for research-use only (RUO).
Telehealth Regulations in Washington, D.C.
State Licensing
OmniRx Health providers are licensed by the DC Board of Medicine to deliver telehealth services throughout the District.
Telehealth Law
The District has progressive telehealth laws that support comprehensive virtual care for its residents.
Pharmacy Access
DC pharmacies throughout all eight wards provide prescription services with convenient same-day or next-day delivery options.
Insurance Notes
DC requires telehealth coverage parity, and DC Medicaid covers virtual visits for eligible District residents.
Frequently Asked Questions
Common questions about medical weight loss and telehealth access in Washington, D.C.
Explore Related Medical Weight Loss Pages
Direct links to specific treatments and other states.